VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

BSH 2020 | Enhanced risk stratification in pediatric ALL

Anthony Moorman, PhD, Newcastle University, Newcastle, UK, discusses a risk stratification study from the Children’s Oncology Group in acute lymphoblastic leukemia (ALL) patients at BSH 2020. The study, which analysed over 21,000 patients to determine risk factors, including white blood cell count and minimal residual disease, to calculate individual risk scores as continuous variables, will be presented at ASH 2020. Prof. Moorman highlights how the results of this study will influence future clinical trial design. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter